Brexit Agreement – what now?
After intensive negotiations, the European Union (EU) and the United Kingdom (UK) agreed on a provisional Trade and Cooperation Agreement on 24 December 2020. By the end of the year, all remaining
Complex distribution service supports fulfilling all demands of the Pharmaceutical industry, from distribution of single product to setting up of EU distribution network, including the certification.
To offer the best care possible for your product and to maximize its potential, we could also utilize our network of key distributors as the last piece to the puzzle of Market Access.
We provide complex distribution support and advice to healthcare product manufacturers to reach their wholesale, retail and hospital customers. We have the system capabilities and operational expertise in warehousing in full compliance with GDP to meet all the demands of the Pharmaceutical industry, including cryostorage.
Our Range of Distribution services:
After intensive negotiations, the European Union (EU) and the United Kingdom (UK) agreed on a provisional Trade and Cooperation Agreement on 24 December 2020. By the end of the year, all remaining
During an inspection of a manufacturer of solid oral dosage forms the FDA observed incidences of water leakage from the ceiling of the encapsulation room: Capsules were exposed to leaks during multiple batch encapsulation operations.
Currently, on-site GMP/GDP inspections may not be possible because of reasons linked to the Covid-19 pandemic. As a result, Distant Assessments can support and help determining compliance with GMP/GDP principles
PHARMA REVOLTA, s. r. o., Rybné námestie 1, 811 02 Bratislava – mestská časť Staré Mesto, Slovak Republic
Email: info@pharev.com
Copyright: © pharma revolta 2020 ¦ nuovo.agency